Injectional verapamil vs saline (short‐term)
Treatment‐related adverse effects · men with Peyronie's disease (palpable plaque or pain)
1 finding from 1 review
- no estimate extracted1 study · 14 participantsVery low
Findings
What do systematic reviews say?
1,733 questions · 1,794 findings · 326 reviews · Headline outcomes only
No studies found 243 · 13.5%GRADE not reported 96 · 5.4%Very low 597 · 33.3%Low 506 · 28.2%Moderate 303 · 16.9%High 49 · 2.7%
Injectional verapamil vs saline (short‐term)
Degree of penile curvature · men with Peyronie's disease (palpable plaque or pain)
1 finding from 1 review
- no estimate extracted1 study · 14 participantsVery low
Injectional verapamil vs saline (short‐term)
Treatment discontinuation · men with Peyronie's disease (palpable plaque or pain)
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Penile traction therapy vs no treatment (short‐term)
Outcomes ( · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Penile traction therapy vs no treatment (short‐term)
Patient‐reported ability to have intercourse · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Penile traction therapy vs no treatment (short‐term)
Quality of life · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)
1 finding from 1 review
- no estimate extracted1 study · 82 participantsVery low
Penile traction therapy vs no treatment (short‐term)
Treatment‐related adverse effects · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)
1 finding from 1 review
- no estimate extracted1 study · 90 participantsVery low
Penile traction therapy vs no treatment (short‐term)
Degree of penile curvature · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)
1 finding from 1 review
- no estimate extracted1 study · 89 participantsVery low
Penile traction therapy vs no treatment (short‐term)
Treatment discontinuation · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)
It is very uncertain whether penile traction therapy changes discontinuation from treatment compared with no treatment (short‐term) (very low certainty).
1 finding from 1 review
- RR 0.86 [0.31, 2.36]2 studies · 182 participantsVery low
Longer vs shorter duration of nicotine patch therapy
Smoking cessation · people who smoke
1 finding from 1 review
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 7078 participantsLow
Longer vs shorter duration of nicotine patch therapy
Overall serious adverse events · people who smoke
1 finding from 1 review
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 1173 participantsVery low
Longer vs shorter duration of nicotine patch therapy
Treatment withdrawal · people who smoke
1 finding from 1 review
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 648 participantsVery low
Longer vs shorter duration of combination nicotine replacement therapy
Smoking cessation ‐ 16 weeks versus 8 weeks · people who smoke
It is very uncertain whether longer changes smoking cessation ‐ 16 weeks versus 8 weeks compared with shorter duration of combination nicotine replacement therapy (very low certainty).
1 finding from 1 review
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyRR 0.96 [0.75, 1.23]1 study · 637 participantsVery low
Longer vs shorter duration of combination nicotine replacement therapy
Smoking cessation · people who smoke
Longer showed no clear difference in smoking cessation ‐ 6 weeks versus 2 weeks compared with shorter duration of combination nicotine replacement therapy (low certainty).
1 finding from 1 review
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyRR 1.11 [0.94, 1.31]1 study · 987 participantsLow
Longer vs shorter duration of combination nicotine replacement therapy
SAEs · people who smoke
It is very uncertain whether longer changes overall SAEs ‐ 26 weeks versus 8 weeks compared with shorter duration of combination nicotine replacement therapy (very low certainty).
3 findings from 1 review
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyRR 1.63 [0.6, 4.42]1 study · 544 participantsVery low
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 637 participantsVery low
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 987 participantsVery low
Longer vs shorter duration of combination nicotine replacement therapy
Treatment withdrawal · people who smoke
1 finding from 1 review
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)
Limb salvage · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in limb salvage rate compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).
1 finding from 1 review
- Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes onlyRR 0.84 [0.49, 1.45]2 studies · 936 participantsLow
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)
Secondary patency (24 months) · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in vessel or graft secondary patency compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).
1 finding from 1 review
- Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes onlyRR 0.92 [0.67, 1.26]3 studies · 1092 participantsLow
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)
Adverse events resulting from DUS surveillance · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
- Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)
All‐cause mortality · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in all‐cause mortality compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).
1 finding from 1 review
- Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes onlyRR 1.11 [0.7, 1.74]1 study · 594 participantsLow